Dr. Keshav Kumar Singh

  • Home
  • Dr. Keshav Kumar Singh
Image
Image
Founder & CEO

Dr. Keshav Kumar Singh

Dr. Singh has a very large experience in the management of all endocrine diseases, from thyroid, parathyroid, adrenal & pituitary diseases to diabetes

Working with leading groups of hospitals like MAX HOSPITAL , KAILASH HOSPITALS , Shanti Gopal Hospital Indrapuram.

PROFESSIONAL QUALIFICATION

DM Endocrinology, BHU, Varanasi (1999)
MD Medicine, SMS Medical College , Jaipur (1995)
MBBS, RMCH, Ranchi (1991)

PROFESSIONAL EXPERIENCE

Image

Worked as a senior resident Dept. of Endocrinology (SGPGI) Lucknow

Image

Worked as DM resident in Endocrinology , LLRM Medical College Meerut

Image

Worked as DM resident in Department of Endocrinology in I.M.S B.H.U , Varanasi.

Image

Worked as Senior Consultant Diabetologist and Endocrinologist in Rajeshwar Hospital & Magadh Hospital in Patna.

Image

Worked as a visiting consultant in different reputed Hospital like – Jeevak Heart Hospital, Heart Hospital , Sri Ram Hospital in Patna

Image

Presently working as Endocrinologist in Kailash Group of Hospitals , Noida and Delhi

Image

Worked as Senior Consultant Diabetologist and Endocrinologist in Max Hospital Patparganj, Delhi

Image

Worked as Senior Consultant Diabetologist and Endocrinologist in Deepak Memorial Hospital

Image

Worked as Senior Consultant Diabetologist and Endocrinologist in Dharamshila Cancer Hospital And Research Centre, Delhi

AREAS OF EXPERTISE

Experienced in treating adult as well as paediatric endocrinological disorders like -

  • Diabetes including gestational diabetes
  • Thyroid disorders
  • Obesity
  • Osteoporosis
  • Erectile dysfunction and other male sexual disorders
  • Female hormonal disorders like PCOS, galactorrhea
  • Pituitary diseases
  • Short stature including growth hormone deficiency
  • Delayed and early puberty
  • Cushing’s syndrome, steroid over dosage and adrenal disease
  • Rickets, Osteomalacia, hyperparathyroidism and other metabolic bone diseases
  • Hypogonadism, Turner’s syndrome, ovarian & testicular failure, ambiguous genitalia

TRAINING WORK

  • Radio Immuno Assay (RIA) techniques and their clinical forms, Bhabha Atomic Research Centre, Mumbai
  • Problem-based learning in Medical Education. National Training Centre, IMS. BHU, Varanasi
  • Cytogenetics Department of Zoology, BHU, Varanasi.

PRESENTATION and SOCIAL WORK

  • Invited as a guest speaker in Army Hospital , Danapur on NEWER INSULINS.
  • Invited as a guest speaker in Railway Hospital , Hajipur on recent Management in T2DM
  • Invited as a Speaker on the Topic of Thyroid Disorder in Pregnancy by Bihar Obstetrics and Gynaecologist Society
  • Invited as a speaker to deliver a lecture on Diabetes , Thyroid, Obesity, Puberty, Sex and Osteoporosis , Insulin and other Endocrine Problems by ENDOCRINE SOCIETY OF INDIA
  • Invited as a Chairperson and Panelist in Different Local Level CME program in Bihar, Ghaziabad, Delhi and Noida .
  • Invited as Speaker , Chairperson in Different CME program by Novartis and other MNCs in Delhi on Different topics of Diabetes and Thyroid management
  • Invited as a Chairperson by ISBMR in UP Chapter.
  • Chairperson in Diabetes update organised by EADSG (East Africa Diabetes Study Group) held in Nairobi, Kenya, 2016
  • Speaker in Role Of Linagliptin in the management of Type-2 Diabetes organised by ESI Hospital, Noida, 2016
  • Speaker in 9th Annual Conference Of MFS on Diabetes and NASH held in India International Centre, New Delhi, 2016
  • Chairperson in Best Of ADA held in Delhi, 2016
  • Panelist in CliniEx held in Delhi, 2016
  • Speaker in Diabetes Update organised by East Delhi Doctors Association, Delhi, 2016
  • Speaker in Role Of SGLT2 Inhibitor in the management of Type 2 Diabetes held in Delhi, 2017
  • Speaker in GLP1 Agonist held in Noida, 2017
  • Chairperson Best of ADA held in Delhi, 2017
  • Speaker in Role Of Basal Insulin in management of Type 2 Diabetes held in Delhi, 2017
  • Speaker in Vitamin D and Bone Health held in Noida, 2017
  • Speaker in Role of newer and diabetic agents in the management of Type 2 Diabetes Mellitus among the physicians of Noida, 2018
  • Speaker in Vitamin D and Bone Health held in Noida, 2017
  • Speaker in Role of newer and diabetic agents in the management of Type 2 Diabetes Mellitus among the physicians of Noida, 2018
  • Speaker SGLT2 Inhibitor and CV safety held in Delhi, 2018
  • Participated in an Interview with NDTV on Endocrine health
  • Chairperson Cardio Diabetic Conference held in Goa, 2018
  • Latest guidelines for the management of Type 2 Diabetes, 2019
  • Role of FIASP (Fastest Acting Insulin) in API, Noida chapter, 2019
  • Speaker in Thyroid disorders in pregnancy, Delhi, 2019
  • Speaker in Diabetic dyslipidemia
  • Speaker in role of SGLT 2 inhibitor, Ghaziabad
  • Speaker in Thyroid disorders in pregnancy, Obstetrics and Gynaecological society, Dhanbad, 2019
  • Chairperson in Role of saroglitazar in Diabetic dyslipidemia, 2019
  • Speaker in hypothyroidism in pregnancy, Modi nagar, 2019
  • Speaker in Cardio-renal benefits of SGLT 2 inhibitors, Noida, 2019
  • Speaker in Glargine in management of Type 2 Diabetes, Ghaziabad, 2020
  • Speaker in Hypothyroidism & Dyslipidemia in adults, Noida, 2020
  • Speaker in The place of sulphonylureas in recent guidelines, 2020 (Webinar)
  • Speaker in Remogliflozin inspire India CME, 2020 (Webinar)
  • Speaker in Basal Insulin Titration, 2020 (Webinar)
  • Speaker in Individualised treatment approach with Gliclazide in management of Type 2 Diabetes, 2020 (Webinar)
  • Speaker in Linagliptin across the cardio-metabolic renal spectrum: Simplicity in management of Type 2 DM, 2021(Webinar)
  • Speaker in L.G.A.C.Y Meets, 2021 (Webinar)
  • Speaker in U-COT: Udapa Circle Of Trust, 2021(Webinar)
  • Speaker in Glucodynamics of modern Sulphonylureas, 2021(Webinar)
  • Case based discussion using RSSDI, ESI therapeutic wheel, 2021
  • Insulin titration with basal insulin addressing glycemic target in patient centric fashion, 2021
  • Place of sulphonylureas in recent guidelines, 2022 (Webinar)
  • Optimising PPBS management with Ripaglinide and Voglibose, 2022 (Webinar)
  • Optimising treatment regiment in T2DM patients simplicity with Linagliptin, 2022 (Webinar)
  • DPP 4 Inhibitors and basal insulin in T2DM challenging clinical scenarios, 2022 (Webinar)
  • CME on Hypertension and Diabetes, 2022 (Webinar)
  • Optimising treatment regiment in T2DM patients simplicity with Linagliptin, 2022 (Webinar)
  • Evaluation of Glycosylated Haemoglobin in Indian Diabetics and Therapy, A multi-centric, retrospective, cross-section study ( TIGHT-II STUDY), 2022 (Webinar)
  • Vildagliptin right add-on Therapy, 2022 (Webinar)
  • Basal Insulin Simplify the link between timely insulinisation and optimum glycemic control, 2022 (Webinar)
  • Addressing Glycemic Pentade and Ominous Octate, 2023 (Webinar)
  • Diabetes management during fasting and feasting, 2023 (Webinar)
  • L.G.A.C.Y Meet 2023 (Linagliptin plus Apmagliflozin for Glycometabolic benefits and Optimum cardiorenal risk Reduction)
  • T3 hormone management, 2023
  • PRIDE Update, 2023 (Panel Discussion On Organ Protection in Diabetes and Hypertensive Patients)

NATIONAL AND INTERNATIONAL CONFERENCE

  • Attended International Congress of Endocrinology (ICE). Kyoto, 2010.
  • Attended Asia Pacific Insulin Maximisation Program(APIMAX). American Diabetes Association Conference. Vietnam, 2011.
  • Attended As a Chairperson at International Academy of Cardiovascular Sciences. Vietnam, 2011.
  • Attended the International Diabetes Federation in Dubai, 2011.
  • Participated SPRITE Study in patients on Insulin Glargine on Health Related quality of Life.
  • Attended EASD - European Association for the Study of Diabetes in Lisbon, 2011.
  • Attended AMAC Gold 2012 in Hong Kong.
  • Attended Endocrine Summit in Mumbai, 2012
  • Attended 10th Asia and Oceania Thyroid Association (AOTA) Congress in Bali, Indonesia, 2012.
  • Attended Dimension In Diabetes organised by Endocrine Society held in Mumbai, 2016
  • Attended ENDO update focus on pituitary gland held at Kolkata, 2016
  • Attended Endocrine Summit held in Mumbai, 2016
  • Attended ESI Conference held in Delhi, 2016
  • Attended Endocrine Summit held in Mumbai, 2017
  • Participated in TIGHT study (The Investigation Of Glycosylated Haemoglobin On Therapy In Indian Diabetes), 2017
  • Participated in Train to Trainer Program conducted by Endocrine Society, 2017
  • Participated in ESI Conference held in Trivandrum, India, 2017
  • Member of several advisory boards and research societies.
  • Participated in RAAS (Real world Azilsartan efficacy Assessment Study) India, 2018
  • Participated in TIGHT Study, 2018